Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00270634 · ClinicalTrials.gov registry record · Phase 2
Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
A Phase 2 study, sponsored by Aurinia Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 334
- Enrollment target
NCT00270634 is a Phase 2 study that has completed, run by Aurinia Pharmaceuticals. The registered enrollment target is 334 participants.
The verdict
NCT00270634, a Phase 2 study, has completed, sponsored by Aurinia Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 334 participants
- Enrollment target
Study Summary
This study will see if voclosporin is safe and effective in preventing kidney transplant rejection.
Interventions
- DRUG Voclosporin
- DRUG tacrolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00270634
The ClinicalTrials.gov registry entry for NCT00270634 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aurinia Pharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Voclosporin is the first listed.
NCT00270634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00270634 about?
NCT00270634 is a clinical study titled "Study of ISA247 (Voclosporin) in De Novo Renal Transplantation". This study will see if voclosporin is safe and effective in preventing kidney transplant rejection.
What is the current status of trial NCT00270634?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 334 participants. The study started on 2006-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00270634?
The interventions under investigation include: Voclosporin (DRUG), tacrolimus (DRUG).
Who is sponsoring clinical trial NCT00270634?
This trial is sponsored by Aurinia Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.